Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn’s DiseaseThe American journal of gastroenterology, 2021-10, Vol.116 (1), p.S367-S367 [Peer Reviewed Journal]2021 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000776688.39678.45Full text available |
|
2 |
Material Type: Article
|
BIOM-64. TARGETING IDENTIFICATION OF HOST-BRAIN CANCER SYSTEMIC CYTOKINE SIGNALLING FOR EARLY DETECTION AND TUMOUR SUB-TYPINGNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii19-vii19 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.074Full text available |
|
3 |
Material Type: Article
|
BIOM-09. GUIDING PRECISION THERAPEUTICS THROUGH INTERROGATING ONCOGENIC PATHWAY ACTIVATIONNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii5-vii6 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.019Full text available |
|
4 |
Material Type: Article
|
BIOM-11. ROR1 MRNA EXPRESSION IN GLIOMA - A NOVEL PROGNOSTIC BIOMARKERNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii6-vii6 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.021Full text available |
|
5 |
Material Type: Article
|
BIOM-06. IDENTIFICATION OF AN INFLAMMATORY BIOMARKER SIGNATURE IN PLASMA-DERIVED EXTRACELLULAR VESICLES OF GLIOBLASTOMA PATIENTSNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii5-vii5 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.016Full text available |
|
6 |
Material Type: Article
|
BIOM-30. ANALYSIS OF GLIOMA-RELATED GENES USING A BREAKTHROUGH AMPLIFICATION TECHNIQUE FOR CELL-FREE DNA IN CEREBROSPINAL FLUIDNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii10-vii11 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.040Full text available |
|
7 |
Material Type: Article
|
BIOM-17. SPYING ON GLIOMAS: LONGITUDINAL CSF AS A PLATFORM FOR GLIOMA MONITORING AND RESPONSE BIOMARKER DISCOVERYNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii7-vii7 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.027Full text available |
|
8 |
Material Type: Article
|
BIOM-50. THE IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF CIRCULAR RNA CIRC_63706 IN SONIC HEDGEHOG MEDULLOBLASTOMASNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii16-vii16 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.060Full text available |
|
9 |
Material Type: Article
|
BIOM-18. CLINICOGENOMIC PREDICTORS FOR THE PATTERN OF FAILURE IN HIGH-GRADE GLIOMANeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii7-vii8 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.028Full text available |
|
10 |
Material Type: Article
|
BIOM-49. A PILOT STUDY OF CEREBROSPINAL FLUID EXOSOMAL SMALL RNA-SEQUENCING IN PEDIATRIC MEDULLOBLASTOMA PATIENTS ON THE NEXT CONSORTIUM “HEAD START” 4 PROTOCOLNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii15-vii16 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.059Full text available |
|
11 |
Material Type: Article
|
BIOM-47. PREDICTORS OF SEIZURE AT ONSET USING A FUNCTIONAL VARIANT ANALYSIS OF TARGETED NEXT GENERATION SEQUENCING IN GBMNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii15-vii15 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.057Full text available |
|
12 |
Material Type: Article
|
BIOM-58. ROLE OF CD79B Y196 MUTATION IN PCNSL AS A POTENT PREDICTIVE MARKER FOR FAVORABLE RESPONSE TO R-MPV TREATMENT AND DEVELOPMENT OF RAPID ALL-IN-ONE GENOTYPING SYSTEM FOR MOLECULAR MARKERS OF PCNSLNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii18-vii18 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.068Full text available |
|
13 |
Material Type: Article
|
BIOM-08. IL13RA2 AS A LIQUID BIOPSY BIOMARKER FOR NERVOUS SYSTEM TUMORSNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii5-vii5 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.018Full text available |
|
14 |
Material Type: Article
|
BIOM-41. IDENTIFICATION OF GLIOMA CELLS BY PROFILING SINGLE-CELL BIOPHYSICAL PROPERTIES THROUGH MULTICONSTRICTION MICROFLUIDIC CHANNELSNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii13-vii13 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.051Full text available |
|
15 |
Material Type: Article
|
BIOM-38. TETRASPANIN 12 AS A TUMOR SUPPRESSOR AND BIOMARKER PREDICTING GOOD PROGNOSIS OF MALIGNANT GLIOMANeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii12-vii13 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.048Full text available |
|
16 |
Material Type: Article
|
BIOM-48. HOXD12 IS AN INDEPENDENTLY PROGNOSTIC AGE-ASSOCIATED INDICATOR FOR POOR SURVIVAL IN OLIGODENDROGLIOMANeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii15-vii15 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.058Full text available |
|
17 |
Material Type: Article
|
BIOM-32. DNA METHYLATION SUBCLASSES PREDICT THE BENEFIT FROM GROSS TOTAL TUMOR RESECTION IN IDH-WILDTYPE GLIOBLASTOMA PATIENTSNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii11-vii11 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.042Full text available |
|
18 |
Material Type: Article
|
BIOM-53. SPECIFIC MICRORNA EXPRESSION PATTERN PREDICTS RECURRENCE IN ATYPICAL MENINGIOMANeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii16-vii17 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.063Full text available |
|
19 |
Material Type: Article
|
BIOM-24. TARGETED NEXT-GENERATION SEQUENCING (NGS) OF TEMPORALLY MATCHED CEREBROSPINAL FLUID (CSF) AND TUMOR TISSUE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii9-vii9 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.034Full text available |
|
20 |
Material Type: Article
|
BIOM-37. EVALUATION OF TEMPORALIS MUSCLE THICKNESS WITH TOXICITY AND SURVIVAL IN GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATIONNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii12-vii12 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.047Full text available |